Recurrent erysipelas: predisposing factors and costs of prophylaxis

Clicks: 279
ID: 117101
1970
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
After an average follow-up time of three years, recurrent erysipelas was observed in 29% of 143 patients admitted primarily with erysipelas. Nineteen patients (13%) had two or more recurrences during this period. The predisposing factor with the highest recurrence rate was venous insufficiency. Regu …
Reference Key
c1970infectionrecurrent Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Jorup-Rönström C;Britton S;;
Journal Infection
Year 1970
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/3110071
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine adult female male aged middle aged Recurrence anti-bacterial agents / therapeutic use risk cost-benefit analysis erysipelas / drug therapy erysipelas / etiology* c jorup-rönström s britton pmid:3110071 doi:10.1007/bf01650206 internal medicine infectious diseases general practice / family medicine

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.